BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 3215280)

  • 1. Discriminative stimulus properties of physostigmine in rats.
    Tang AH; Franklin SR
    Eur J Pharmacol; 1988 Aug; 153(1):97-104. PubMed ID: 3215280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterization of the physostigmine stimulus in rats.
    Jung M; Perio A; Worms P; Soubrie P
    Psychopharmacology (Berl); 1988; 95(4):553-5. PubMed ID: 3145526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scopolamine-physostigmine combination does not substitute for nicotine.
    Schechter MD
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 May; 19(3):499-508. PubMed ID: 7624500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholinergic drug effects on a delayed conditional discrimination task in the rat.
    Herremans AH; Hijzen TH; Olivier B; Slangen JL
    Behav Neurosci; 1995 Jun; 109(3):426-35. PubMed ID: 7662153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the discriminative stimulus effects of physostigmine in the rat.
    Locke KW; Gorney B; Cornfeldt M; Fielding S
    J Pharmacol Exp Ther; 1989 Jul; 250(1):241-6. PubMed ID: 2746500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine and arecoline as discriminative stimuli: involvement of a non-cholinergic mechanism for nicotine.
    Meltzer LT; Rosecrans JA
    Pharmacol Biochem Behav; 1988 Mar; 29(3):587-93. PubMed ID: 3362953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discriminative stimulus properties of arecoline: a new approach for studying central muscarinic receptors.
    Meltzer LT; Rosecrans JA
    Psychopharmacology (Berl); 1981; 75(4):383-7. PubMed ID: 6803285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the scopolamine stimulus in rats.
    Jung M; Perio A; Worms P; Biziere K
    Psychopharmacology (Berl); 1988; 95(2):195-9. PubMed ID: 3137597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholinergic blockade and response timing in rats.
    SoffiƩ M; Lejeune H
    Psychopharmacology (Berl); 1992; 106(2):215-20. PubMed ID: 1549649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of intracerebroventricular pirenzepine on muscarinic discriminations in rats.
    Jung M; Perio A; Terranova JP; Worms P; Biziere K
    Eur J Pharmacol; 1987 Jul; 139(1):111-6. PubMed ID: 3653237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discriminative stimulus properties of muscarinic agonists.
    Jung M; Costa L; Shearman GT; Kelly PH
    Psychopharmacology (Berl); 1987; 93(2):139-45. PubMed ID: 3122245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative stimulus properties of NIK-247 and tetrahydroaminoacridine, centrally active cholinesterase inhibitors, in rats.
    Yamamoto T; Ohno M; Sugimachi K; Ueki S
    Pharmacol Biochem Behav; 1993 Apr; 44(4):769-75. PubMed ID: 8469688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholinergic agents and delay-dependent performance in the rat.
    Buxton A; Callan OA; Blatt EJ; Wong EH; Fontana DJ
    Pharmacol Biochem Behav; 1994 Dec; 49(4):1067-73. PubMed ID: 7886077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scopolamine and methylscopolamine differentially affect fixed-consecutive-number performance of male and female Wistar rats.
    van Haaren F; van Hest A; van Hattum T
    Pharmacol Biochem Behav; 1989 Jun; 33(2):361-5. PubMed ID: 2813474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cholinergic pharmacology of tetrahydroaminoacridine in vivo and in vitro.
    Hunter AJ; Murray TK; Jones JA; Cross AJ; Green AR
    Br J Pharmacol; 1989 Sep; 98(1):79-86. PubMed ID: 2804555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scopolamine self-administration: cholinergic involvement in reward mechanisms.
    Glick SD; Guido RA
    Life Sci; 1982 Aug; 31(9):909-13. PubMed ID: 7176819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholinergic mediation of the discriminative stimulus properties of clozapine.
    Nielsen EB
    Psychopharmacology (Berl); 1988; 94(1):115-8. PubMed ID: 3126519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of azaprophen, scopolamine and trihexyphenidyl on schedule-controlled behavior, before and after chronic physostigmine.
    Genovese RF
    Eur J Pharmacol; 1990 Feb; 176(3):271-9. PubMed ID: 2328755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chin rub CRs are elicited by flavors associated with apomorphine, scopolamine, methscopolamine, physostigmine and neostigmine.
    Smith RJ; Parker LA
    Pharmacol Biochem Behav; 1985 Oct; 23(4):583-9. PubMed ID: 4070336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perceptual bisection in rats: the effects of physostigmine, scopolamine and pirenzepine.
    Shurtleff D; Raslear TG; Genovese RF; Simmons L
    Physiol Behav; 1992 Feb; 51(2):381-90. PubMed ID: 1557449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.